Want to see KYMR full AI Analyst Report?
Kymera Therapeutics (KYMR) Ownership Overview
11.97% Insiders
39.89% Mutual Funds
0.15% Other Institutional Investors
15.31% ETFs
32.69% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 55.35% of the company’s stock is owned by Institutional Investors, 11.97% is owned by Insiders, and 32.69% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 04, 2026 | xxxxxxxxxxxxx | $744297 | |
Jun 26, 2026 | xxxxxxxxxxxxx | $173665077 | |
May 27, 2026 | xxxxxxxxxxxxx | $317897 | |
Mar 04, 2026 | xxxxxxxxxxxxx | $515567 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $26265508 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $57434534 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $105408448 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $583326 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,657,242 | Institution | 10.41% | 1,096,266,554 | |
| 7,955,916 | Insider | 9.57% | 1,007,457,643 | |
| 5,962,961 | Institution | 7.17% | 755,089,751 | |
| 5,194,466 | Institution | 6.25% | 657,775,230 | |
| 3,414,247 | Institution | 4.11% | 432,346,098 | |
| 3,124,571 | Institution | 3.76% | 395,664,426 | |
| 2,257,207 | Institution | 2.71% | 285,830,122 | |
| 2,046,104 | Institution | 2.46% | 259,098,150 | |
| 1,796,469 | Institution | 2.16% | 227,486,869 | |
| 1,352,248 | Institution | 1.63% | 171,235,164 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,194,466 | Institution | 6.25% | 657,775,230 | |
| 3,414,247 | Institution | 4.11% | 432,346,098 | |
| 2,257,207 | Institution | 2.71% | 285,830,122 | |
| 2,046,104 | Institution | 2.46% | 259,098,150 | |
| 1,796,469 | Institution | 2.16% | 227,486,869 | |
| 1,352,248 | Institution | 1.63% | 171,235,164 | |
| 1,120,941 | Institution | 1.35% | 141,944,759 | |
| 1,007,268 | Institution | 1.21% | 127,550,347 | |
| 924,967 | Institution | 1.11% | 117,128,571 | |
| 917,740 | Institution | 1.10% | 116,213,416 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,100,268 | Institution | 2.53% | 234,788,960 | |
| 1,586,317 | Institution | 1.91% | 194,339,696 | |
| 1,496,561 | Institution | 1.80% | 167,300,554 | |
| 1,127,099 | Institution | 1.36% | 138,080,898 | |
| 833,887 | Institution | 1.00% | 93,220,228 | |
| 825,060 | Institution | 0.99% | 92,233,457 | |
| 584,168 | Institution | 0.70% | 71,618,997 | |
| 487,534 | Institution | 0.59% | 59,771,668 | |
| 386,696 | Institution | 0.47% | 47,374,127 | |
| 364,080 | Institution | 0.44% | 40,700,503 |
FAQ
Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 11.97% is held by insiders, and 32.69% is held by retail investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.69% of Kymera Therapeutics (KYMR) stock is held by retail investors.
Who owns the most shares of Kymera Therapeutics (KYMR)?
Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.